IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 336
Titolo Tipologia Data di pubblicazione Autore(i) File
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology 1.1 Articolo in rivista 2015 Frett, Brendan; Carlomagno, Francesca; Moccia, Marialuisa; Brescia, Annalisa; Federico, Giorgia; De Falco, Valentina; Admire, Brittany; Chen, Zhongzhu; Qi, Wenqing; Santoro, Massimo; Li, Hong yu
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway. 1.1 Articolo in rivista 2015 Visciano, Carla; Liotti, Federica; Prevete, Nella; Cali', G; Franco, R; Collina, F; DE PAULIS, Amato; Marone, Gianni; Santoro, Massimo; Melillo, ROSA MARINA
Genetics: The genomic landscape of papillary thyroid carcinoma 1.2 Recensione in rivista 2014 Santoro, Massimo; Melillo, ROSA MARINA
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 1.1 Articolo in rivista 2014 Moretti, S; Menicali, E; Voce, P; Morelli, S; Cantarelli, S; Sponziello, M; Colella, R; Fallarino, F; Orabona, C; Alunno, A; de Biase, D; Bini, V; Mameli, Mg; Filetti, S; Gerli, R; Macchiarulo, A; Melillo, ROSA MARINA; Tallini, G; Santoro, Massimo; Puccetti, P; Avenia, N; Puxeddu, E.
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies. 1.1 Articolo in rivista 2014 Bossi, D; Carlomagno, Francesca; Pallavicini, I; Pruneri, G; Trubia, M; Raviele, Pr; Marinelli, A; Anaganti, S; Cox, Mc; Viale, G; Santoro, Massimo; Di Fiore, Pp; Minucci, S.
RET recognition of GDNF-GFRα1 ligand by a composite binding site promotes membrane-proximal self-association. 1.1 Articolo in rivista 2014 Goodman, Km; Kjær, S; Beuron, F; Knowles, Pp; Nawrotek, A; Burns, Em; Purkiss, Ag; George, R; Santoro, Massimo; Morris, Ep; Mcdonald, N. Q.
NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. 1.1 Articolo in rivista 2014 Bellelli, Roberto; Castellone, Md; Guida, T; Limongello, R; Dathan, Na; Merolla, Francesco; Cirafici, Am; Affuso, A; Masai, H; Costanzo, Vincenzo; Grieco, Domenico; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluation 1.1 Articolo in rivista 2014 Frett, B; Moccia, M; Carlomagno, Francesca; Santoro, Massimo; Li, Hy
Update: The Status of Clinical Trials of Kinase Inhibitors in Thyroid Cancer. 1.1 Articolo in rivista 2014 S. A., Wells; Santoro, Massimo
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 1.1 Articolo in rivista 2014 DI MARO, Gennaro; Salerno, Paolo; Unger, Kristian; Orlandella, FRANCESCA MARIA; Monaco, Mario; Chiappetta, Gennaro; Thomas, Gerry; Oczko Wojciechowska, Malgorzata; Masullo, Mariorosario; Jarzab, Barbara; Santoro, Massimo; Salvatore, Giuliana
Central role of RET in thyroid cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Attacking cancer with molecularly targeted agents 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Oncogenic rearrangements driving ionizing radiation-associated human cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model. 1.1 Articolo in rivista 2013 Y., Ward; R., Lake; P. L., Martin; K., Killian; Salerno, Paolo; T., Wang; P., Meltzer; M., Merino; S. y., Cheng; Santoro, Massimo; G., Garcia Rostan; K., Kelly
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. 1.1 Articolo in rivista 2013 S. A., Wells; F., Pacini; B. G., Robinson; Santoro, Massimo
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer. 1.1 Articolo in rivista 2013 De Falco, V; Buonocore, Preziosa; Muthu, M; Torregrossa, L; Basolo, F; Billaud, M; Gozgit, Jm; Carlomagno, Francesca; Santoro, Massimo
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation. 1.1 Articolo in rivista 2013 Krishnamoorthy, GNAMA PRAKASAM; Guida, Teresa; Alfano, L; Avilla, Elvira; Santoro, Massimo; Carlomagno, Francesca; Melillo, ROSA MARINA
Tumor Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis 1.1 Articolo in rivista 2013 Ferraro, A; Schepis, F; Leone, V; Federico, A; Borbone, E; Pallante, P; Berlingieri, Mt; Chiappetta, G; Monaco, M; Palmieri, D; Chiariotti, Lorenzo; Santoro, Massimo; Fusco, Alfredo
NCOA4 inhibits initiation of DNA replication to maintain genome stability 4.2 Abstract in Atti di convegno 2012 Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca
Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases. 1.1 Articolo in rivista 2012 A., Tamburrino; A. A., Molinolo; Salerno, Paolo; R. D., Chernock; M., Raffeld; L., Xi; J. S., Gutkind; J. F., Moley; S. A., Wells; Santoro, Massimo
Mostrati risultati da 21 a 40 di 336
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile